This device is commercially available for use in select international markets.
Premier Therapy.* Premium Platform.** Precise Relief.†
Abbott offers the only neuromodulation systems approved to stimulate a cluster of nerves called the dorsal root ganglion (or DRG). DRG stimulation expands the range of neurostimulation options you can offer, and allows you to treat patients with focal chronic intractable pain in specific anatomical locations such as the hand, foot, knee, hip and groin.
The Proclaim™ DRG implantable pulse generator (IPG) neurostimulation system sets a new standard of care for treating chronic intractable pain by providing clinically superior therapy*,1 in our technologically advanced Proclaim™ DRG platform.
Advanced neurostimulation technologies
The Proclaim DRG IPG offers patients advanced features for convenience and comfort, so they can stay focused on their lives and not their therapy.
Longer Battery Life***,2,3
The Proclaim DRG IPG neurostimulator features a battery life of 6.5 years at nominal settings, potentially reducing the number of procedures and replacement devices, and increasing the time between battery replacements.
Upgradable technology—only from Abbott—allows patients to benefit from our next advancement in chronic pain therapy without surgery. Patients will receive advances easily and painlessly through a simple software upgrade upon market approval.
Convenient Bluetooth®‡ Wireless Programmer Connectivity
Wireless mobile consumer technology enables easy patient use and clinician programming.
- Patients have a familiar and intuitive interface for the St. Jude Medical™ patient controller app using an Apple‡ iPod touch‡ mobile digital device. Patients can use the controller to:
- Turn stimulation on and off
- Adjust stimulation settings
- Cycle through programs
- Assess IPG battery longevity
- Clinicians can use the clinician programmer, featuring an Apple‡ iPad mini‡ mobile digital device and downloadable programming app, to set programming parameters.
Wireless programming also eliminates wires, potentially enhancing patient comfort and convenience.
The Proclaim DRG IPG neurostimulator is MR Conditional, allowing scans of the head and extremities within approved MRI parameters.
Expanding the Treatable Patient Population
The Proclaim™ DRG IPG neurostimulation system is part of our dorsal root ganglion (DRG) portfolio. Our vision is to transform the management of chronic pain by expanding the range of neurostimulation options available and setting a new standard of care to help improve the lives of more patients. Read more about the portfolio and our approach to chronic pain management.